China's Hospitals Must Give Patients Advance Notice On Costs Of Medical Services
This article was originally published in PharmAsia News
Executive SummaryThe Ministry of Health announced regulations Aug. 24 which require hospitals to give patients advance notice of costs before patients make out-of-pocket payments for medicines, medical exams, surgery and medical devices
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.